Pulse Biosciences, Inc.
PLSE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $118 | $44 | $61 | $29 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $6 |
| Other Curr. Assets | $1 | $1 | $1 | $2 |
| Total Curr. Assets | $119 | $45 | $62 | $37 |
| Property Plant & Equip (Net) | $8 | $9 | $10 | $11 |
| Goodwill | $3 | $3 | $3 | $3 |
| Intangibles | $1 | $2 | $3 | $3 |
| Long-Term Investments | $0 | $2 | -$3 | -$3 |
| Tax Assets | $0 | $0 | $3 | $3 |
| Other NC Assets | $1 | -$2 | $0 | $0 |
| Total NC Assets | $13 | $14 | $16 | $18 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $132 | $59 | $78 | $54 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $2 | $3 |
| Short-Term Debt | $1 | $1 | $2 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $4 | $3 | $4 |
| Total Curr. Liab. | $10 | $7 | $6 | $9 |
| LT Debt | $8 | $8 | $74 | $10 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $8 | $8 | $74 | $10 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $9 | $10 | $11 |
| Total Liabilities | $18 | $15 | $80 | $19 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$391 | -$337 | -$295 | -$236 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $505 | $381 | $292 | $272 |
| Total Equity | $115 | $44 | -$2 | $36 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $132 | $59 | $78 | $54 |
| Net Debt | -$109 | -$35 | $15 | -$17 |